S. Mccormack

发表

The licensing of DNA patents by US academic institutions: an empirical survey

R. Cook-Deegan, M. Soucy, Lori Pressman, 2006, Nature Biotechnology.

Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial

B. Wüthrich, I. Erdmann, T. Kündig, 2008, Proceedings of the National Academy of Sciences.

Mechanism of interferon action: RNA-binding activity of full-length and R-domain forms of the RNA-dependent protein kinase PKR--determination of KD values for VAI and TAR RNAs.

C. Samuel, S. Mccormack, C. E. Samuel, 1995, Virology.

Mechanism of interferon action motif I of the interferon-induced, RNA-dependent protein kinase (PKR) is sufficient to mediate RNA-binding activity.

C. Samuel, J. Doohan, S. Mccormack, 1994, Virology.

[25] Protein RNA-binding activity measured by northwestern blot analysis: The interferon-inducible RNA-dependent protein kinase PKR

C. Samuel, S. Mccormack, C. E. Samuel, 1995, Methods in Molecular Genetics.

Mechanism of Interferon Action: Biochemical and Genetic Evidence for the Intermolecular Association of the RNA-Dependent Protein Kinase PKR from Human Cells

C. Samuel, G. Henry, S. Mccormack, 1996 .

Mechanism of interferon action: identification of a RNA binding domain within the N-terminal region of the human RNA-dependent P1/eIF-2 alpha protein kinase.

C. Samuel, S. Mccormack, D. Thomis, 1992, Virology.

Characterization of the heparin-mediated activation of PKR, the interferon-inducible RNA-dependent protein kinase.

C. Samuel, C. George, S. Mccormack, 1996, Virology.

LeRoy Walters’s Legacy of Bioethics in Genetics and Biotechnology Policy

R. Cook-Deegan, S. Mccormack, 2019, Kennedy Institute of Ethics journal.

Mechanism of interferon action. Translational control and the RNA-dependent protein kinase (PKR): antagonists of PKR enhance the translational activity of mRNAs that include a 161 nucleotide region from reovirus S1 mRNA.

C. Samuel, G. Henry, S. Mccormack, 1994, Journal of biological regulators and homeostatic agents.

Intellectual property. Patents, secrecy, and DNA.

R. Cook-Deegan, R M Cook-Deegan, S J McCormack, 2001, Science.

Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial

B. Wüthrich, I. Erdmann, T. Kündig, 2008, Proceedings of the National Academy of Sciences.

An historical perspective on genomic technologies.

D. Galas, S. Mccormack, 2003, Current issues in molecular biology.